https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / J. Exp. Clin. Cancer Res. 2004 Mar;23(1):9-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / J. Exp. Clin. Cancer Res. 2004 Mar;23(1):9-132004-03-01 00:00:002019-02-15 08:51:05Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / Cancer Sci. 2004 Mar;95(3):248-532004-03-01 00:00:002019-02-15 08:48:24Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-02-25 / Cancer Immunol Immunother 2004 Jul;53(7):633-412004-02-25 00:00:002023-03-07 13:15:18Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Int. J. Mol. Med. 2004 Jan;13(1):33-92004-01-01 00:00:002019-02-15 08:53:30Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Breast Dis 2004;20:65-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Breast Dis 2004;20:65-712004-01-01 00:00:002004-01-01 00:00:00Dendritic cell-based therapeutics for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(2):154-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(2):154-632004-01-01 00:00:002019-02-15 08:50:27The immune response to breast cancer, and the case for DC immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(1):62-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(1):62-72004-01-01 00:00:002019-02-15 08:51:06DC-based immunotherapy of B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-82003-12-01 00:00:002019-02-15 08:51:25Dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-822003-12-01 00:00:002019-02-15 08:46:08Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-352003-10-15 00:00:002019-02-15 08:49:35Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
